- 1. (+-)-15-Deoxyspergualin
- [A derivative of the antitumor antibiotic spergualin with immunosuppressant activity. Gusperimus inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells; this agent may suppress growth of certain T-cell leukemia cell lines. (NCI04) ( NCI )] (UMLS (NCI) C0284559) =Organic Chemical; Pharmacologic Substance ;
| - 51. 6-deoxy-3,5 di-O-methyl 6-(3-methyl-3-nitrosoureido)-alpha-D-glucofuranoside
- (UMLS (NCI) C0116847) =Organic Chemical; Pharmacologic Substance ;
|
- 2. (-)-.DELTA.9-Tetrahydrocannabinol
- [A synthetic pill form of delta-9-tetrahydrocannabinol (THC), an active ingredient in marijuana that is used to treat nausea and vomiting associated with cancer chemotherapy. ( NCI )] (UMLS (NCI) C0039663) =Organic Chemical; Pharmacologic Substance ;
=[GA700] ANTIEMETICS;
cannabinoid =NABILONE;
DRONABINOL 10 MG;
DRONABINOL 2.5 MG;
DRONABINOL 5 MG;
| - 52. 63-Desulfohirudin(Hirudo medicinalis isoform HV1)
- [A synthetic recombinant form of the naturally occurring hirudin, the anticoagulant substance found in leech. Desirudin is a selective and almost irreversible inhibitor of thrombin, both free and clot-bound, by blocking its active site. This anticoagulant agent has no effect on other components of the hemostatic system. Desirudin is particularly used to prevent deep vein thrombosis in patients undergoing hip and knee replacement surgery. ( NCI )] (UMLS (NCI) C0378366) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 3. (-)-2'-Deoxy-5-fluoro-3'-thiacytidine
- (UMLS (NCI) C0877876) =Nucleic Acid, Nucleoside, or Nucleotide
| - 53. DE
- [A state in the mid-atlantic United States. Its capital is Dover. ( NCI )] (UMLS (NCI) C0011198) =Geographic Area ;
◊ [central European country bordering on the North and Baltic Seas, capital Berlin. ( CSP )] (UMLS (NCI) C0017480) Geographic Area ; Europe; |
- 4. .delta.-Aminolevulinic acid hydrochloride
- [The hydrochloride salt form of aminolevulinic acid, an aminoketone, used for local photosensitizing therapy. Aminolevulinic acid (ALA) is a metabolic pro-drug that is converted into the photosensitizer protoporphyrin IX (PpIX), which accumulates intracellularly. Upon exposure to light of appropriate wavelength (red, or blue), PpIX catalyzes oxygen to singlet oxygen, an intracellular toxin, which can further react to form superoxide and hydroxyl radicals. This leads to cellular cytotoxic effects. ( NCI )] (UMLS (NCI) C0876231) 5-Amino-4-oxopentanoic Acid HCl;
5-Amino-4-oxopentanoic Acid Hydrochloride;
Aminolevulinic Acid HCl;
AMINOLEVULINIC ACID HYDROCHLORIDE;
Delta-Aminolevulinic Acid HCl;
Delta-Aminolevulinic Acid Hydrochloride =Organic Chemical; Pharmacologic Substance ;
| - 54. De Galantha stain
- [Stain, De Galantha ( HL7V3.0 )] (UMLS (HL7) C1293969) =Laboratory Procedure =ObservationMethod;
|
- 5. .delta.1-Cortisone
- [synthetic anti-inflammatory glucocorticoid derived from cortisone; biologically inert and converted to prednisolone in the liver. ( CSP )] (UMLS (NCI) C0032952) =Steroid; Pharmacologic Substance; Hormone =[HS051] GLUCOCORTICOIDS;
Pregnadienediols;
corticosteroid analog;
=PREDNISONE MISC. POWDER (GM);
PREDNISONE 1 MG/ML;
PREDNISONE 2.5 MG;
PREDNISONE 20 MG;
PREDNISONE 25 MG;
PREDNISONE 5 MG/ML;
PREDNISONE 50 MG;
PREDNISONE 1 MG;
PREDNISONE 10 MG;
prednisolone 1 MG/ML;
PREDNISONE 5 MG | - 55. De novo Acute Myeloid Leukemia with Multilineage Dysplasia
- (UMLS (NCI) C1333259) =Neoplastic Process ;
|
- 6. 1 DEG BURN BACK OF HAND
- [ ] (UMLS (ICD9CM) C0161218) =Injury or Poisoning
| - 56. de novo Myelodysplastic Syndrome
- (UMLS (NCI) C0280451) =Neoplastic Process
|
- 7. 1 DEG BURN FINGR W THUMB
- [ ] (UMLS (ICD9CM) C1112529) Erythema due to burn [first degree] of two or more digits of hand including thumb =Injury or Poisoning
| - 57. De Quervain's Thyroiditis
- (UMLS (NCI) C0342176) =Disease or Syndrome ;
|
- 8. 1'-Demethyl-1'-nitroso-nicotine
- [A yellow, oily liquid nitrosamine that solidifies at cold temperatures and emits toxic fumes of nitrogen oxides when heated to decomposition. Nitrosonornicotine is found in tobacco products and is likely produced by the nitrosation of nicotine during the making and smoking of tobacco products. This substance is only used in research to induce tumors in experimental animals. Exposure to nitrosonornicotine affects the liver and nitrosonornicotine is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0067113) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 58. De Toni-Debre-Fanconi Syndrome
- [constellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration. ( CSP )] (UMLS (NCI) C0015624) =Disease or Syndrome =cystine storage disease;
syndrome;
inborn biological transport disorder;
|
- 9. 1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil
- [antineoplastic antimetabolite; has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. ( CSP )] (UMLS (NCI) C0016343) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
[AN000] ANTINEOPLASTICS;
[AM800] ANTIVIRALS;
deoxyuridine;
fluoropyrimidine;
halocarbon compound;
nucleoside analog;
=FLOXURIDINE 100 MG/ML;
| - 59. Deacetylase
- [An enzyme that hydrolyzes N-acetyl groups. ( NCI )] (UMLS (NCI) C1333261) =Amino Acid, Peptide, or Protein; Enzyme
|
- 10. 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil
- [pyrimidine analog which inhibits viral DNA synthesis. ( CSP )] (UMLS (NCI) C0020811) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=[AM800] ANTIVIRALS;
deoxyuridine;
halocarbon compound;
[OP203] ANTIVIRALS, TOPICAL OPHTHALMIC;
nucleoside analog;
| - 60. Deactivate: discontinue using record in master file, but do not delete from database
- (UMLS (HL7) C1549607) =Intellectual Product =Record-level event code;
|
- 11. 1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein
- [A synthetic C-terminal octapeptide identical to the sequences of the endogenous cholecystokinin hormone. Mimic action of cholecystokinin, sincalide induces gallbladder smooth muscle contraction directly, thereby reducing gallbladder size, inducing bile evacuation, and secretion of pancreatic enzymes. In addition, this agent decreases esophageal sphincter tone and delays gastric emptying via cholinergic signaling. ( NCI )] (UMLS (NCI) C0037167) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =CCK;
[DX101] NON-IONIC CONTRAST MEDIA =SINCALIDE 5 MCG;
| - 61. deacylation
- [ ] (UMLS (CSP) C0597762) =Natural Phenomenon or Process ;
|
- 12. 1-Deamino-8-D-arginine Vasopressin
- [A synthetic octapeptide, and an analogue of human hormone arginine vasopressin with antidiuretic and coagulant activities. Desmopressin binds to V2 receptors in renal collecting ducts which leads to exocytosis of von Willebrand factor (VWF) and tissue plasminogen activator (t-PA) from Weibel-Palade bodies, thereby increasing water resorption. This agent also increases nitric oxide (NO) production via activation of endothelial NO synthase, thereby induces afferent arteriolar vasodilation. Furthermore, desmopressin stimulates the release of factor VIII from endothelial cells mediated through V1a receptor, thereby promotes blood coagulation. ( NCI )] (UMLS (NCI) C0011701) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =[HS702] POSTERIOR PITUITARY;
ADH =1-(3-Mercaptopropionic acid)-8-D-arginine Vasopression Monoacetate;
DESMOPRESSIN 0.1 MG;
DESMOPRESSIN 0.2 MG | - 62. Dead on Arrival (DOA)
- (UMLS (HL7) C1547232) =Intellectual Product =Triage Code;
|
- 13. 1-Deoxy-1-(methylamino)-D-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt)
- [The meglumine salt form of diatrizoate, an organic, iodinated, radiopaque X-ray contrast medium used in diagnostic radiography. The iodine moiety of diatrizoate meglumine is not penetrable by X-rays, therefore blocks the X-ray film exposure by radiation. This makes it possible to distinguish on X-ray film, body parts that contain diatrizoate meglumine from body parts that do not contain this agent and allows for visualization of different body structures. ( NCI )] (UMLS (NCI) C0012005) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =3,5-Bis(acetylamino)-2,4,6-triiodobenzoic Acid;
MEGLUMINE;
Triiodobenzoic Acids;
=3,5-Diacetamido-2,4,6-triiodobenzoic Acid, Sodium Salt;
DIATRIZOATE MEGLUMINE 520 MG/ML;
DIATRIZOATE MEGLUMINE 52 %;
DIATRIZOATE MEGLUMINE 660 MG;
DIATRIZOATE MEGLUMINE 76 %;
DIATRIZOATE MEGLUMINE 34.3 %;
DIATRIZOATE MEGLUMINE 30 %;
DIATRIZOATE MEGLUMINE 85 %;
DIATRIZOATE MEGLUMINE 52.7 %;
DIATRIZOATE MEGLUMINE 18 %;
DIATRIZOATE MEGLUMINE 60 %;
DIATRIZOATE MEGLUMINE 28.5 %;
DIATRIZOATE MEGLUMINE 66 %;
DIATRIZOATE MEGLUMINE 50 % | - 63. DEADrugSchedule
- [DEA schedule for a drug. ( HL7V3.0 )] (UMLS (HL7) C1697989) =Intellectual Product =Controlled Substance;
|
- 14. 1-Deoxy-1-(methylamino)-D-glucitol 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodobenzoate
- [The meglumine salt form of ioxaglate, an organic iodine compound and a radiographic contrast medium. Ioxaglate meglumine blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by ioxaglate meglumine is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of ioxaglate meglumine. (NCI05) ( NCI )] (UMLS (NCI) C0205807) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =IOXAGLATE;
=IOXAGLATE MEGLUMINE 393 MG/ML;
| - 64. DEAE (diethylaminoethyl) resin for transfection
- [ ] (UMLS (CSP) C0599564) =Indicator, Reagent, or Diagnostic Aid ;
|
- 15. 1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
- [The meglumine salt form of iothalamate, an organic iodine compound and a radiographic contrast medium. Iothalamate meglumine blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by iothalamate meglumine is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of iothalamate meglumine. (NCI05) ( NCI )] (UMLS (NCI) C0022033) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =IOTHALAMATE;
MEGLUMINE;
Triiodobenzoic Acids;
=Benzoic Acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, Monosodium Salt;
IOTHALAMATE MEGLUMINE 60 %;
IOTHALAMATE MEGLUMINE 43 %;
IOTHALAMATE MEGLUMINE 17.2 %;
IOTHALAMATE MEGLUMINE 30 %;
IOTHALAMATE MEGLUMINE 52 %;
| - 65. DEAE chromatography
- [ ] (UMLS (CSP) C0598730) =Laboratory Procedure ;
|
- 16. 10,11delta-Amitriptyline Hydrochloride
- [A centrally acting muscle relaxant, chemically similar to amitriptyline hydrochloride with antidepressant activity. The exact mechanism of action of cyclobenzaprine hydrochloride has not been fully determined. However, it primarily acts at the brain stem to reduce tonic somatic motor activity, influencing both gamma and alpha motor neurons. This leads to a reduction in muscle spasms. ( NCI )] (UMLS (NCI) C0125988) =Organic Chemical; Pharmacologic Substance ;
=CYCLOBENZAPRINE;
=CYCLOBENZAPRINE HYDROCHLORIDE 10 MG | - 66. Deaf
- (UMLS (HL7) C1547302) =Intellectual Product =Precaution Code;
|
- 17. 10-Deacetyltaxol
- [An analog of paclitaxel with antineoplastic activity. 10-Deacetyltaxol binds to and stabilizes the resulting microtubules, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and apoptosis. ( NCI )] (UMLS (NCI) C0044663) =Organic Chemical
| - 67. deaf aid
- [physical or electronic technology for assisting the deaf or hard-of-hearing. ( CSP )] (UMLS (CSP) C0542459) =Medical Device ;
=communication disorder aid;
=lipreading;
sign language;
electrotactile communication;
speech viewer;
|
- 18. 15-Deoxyspergualin Hydrochloride
- (UMLS (NCI) C0284558) =Organic Chemical; Pharmacologic Substance ;
| - 68. deaf mutism
- [ ] (UMLS (CSP) C0011052) =Disease or Syndrome ;
|
- 19. 17-Demethoxy-15-methoxy-11-O-methylgeldanamycin, (15R)-
- [A benzoquinone antineoplastic antibiotic isolated from the bacterium Streptomyces hygroscopicus. Herbimycin binds to and inhibits the cytosolic chaperone functions of heat shock protein 90 (HSP90). HSP90 maintains the stability and functional shape of many oncogenic signaling proteins; the inhibition of HSP90 promotes the proteasomal degradation of oncogenic signaling proteins that may be over-expressed or overactive in tumor cells. (NCI04) ( NCI )] (UMLS (NCI) C0062565) =Organic Chemical; Antibiotic ;
| - 69. Deaf nonspeaking, not elsewhere classifiable
- [ ] (UMLS (ICD9CM) C1955777) DEAF, NONSPEAKING NEC;
=Disease or Syndrome |
- 20. 2 DEG BURN BACK OF HAND
- [ ] (UMLS (ICD9CM) C0161228) =Injury or Poisoning
| - 70. Deafness all degrees NOS
- [lack or significant deficiency of the sense of hearing.(CSP)] (UMLS (ICPC) C0011053) (Deafness all degrees NOS; GORTASUNA ZATIZKOA EDO OSOA BIKG; Dovhed alle former/grader IKA; Doofheid alle graden NAO; KUUROUS, KAIKKI ASTEET NUD; Surdite tous degres NP; Taubheit/starke Schwerhoerigkeit NNB; xershut shlema o xelkit; minden fajta n.m. suketseg,; Tutti i gradi di sordita NSA; DOVHET/NEDSATT HORSEL IKA; Surdez todos os graus NE; Sordera parcial/completa NC; DOVHET ALLA GRADER UNS) deafness =Disease or Syndrome ;
=auris; hearing disorder; Diagnosis/Diseases Component; =congenital deafness; noise induced deafness; Central Hearing Loss; Deafness, Sudden |
- 21. 2 DEG BURN FINGR W THUMB
- [ ] (UMLS (ICD9CM) C0161226) =Injury or Poisoning
| - 71. dealkylation
- [The removing of alkyl groups from a compound. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) ( MSH )] (UMLS (CSP) C0011059) =Natural Phenomenon or Process ;
|
- 22. 2'-Deoxy-5-azacytidine
- [An anticancer drug that belongs to the family of drugs called antimetabolites. ( NCI )] (UMLS (NCI) C0049065) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 72. deamidation
- [ ] (UMLS (CSP) C1330964) =Natural Phenomenon or Process ;
|
- 23. 2'-Deoxy-5-trifluoromethyluridine
- [A fluorinated thymidine analog with potential antineoplastic activity. Trifluridine is incorporated into DNA and inhibits thymidylate synthase, resulting in inhibition of DNA synthesis, inhibition of protein synthesis, and apoptosis. This agent also exhibits antiviral activity. (NCI04) ( NCI )] (UMLS (NCI) C0040987) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=dT;
[OP203] ANTIVIRALS, TOPICAL OPHTHALMIC =TRIFLURIDINE 1 % | - 73. deaminase
- [ ] (UMLS (CSP) C0582118) =Amino Acid, Peptide, or Protein; Enzyme
|
- 24. 2'-Deoxycytidine Kinase
- [Deoxycytidine Kinase, encoded by the DCK gene, is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity. (from LocusLink) ( NCI )] (UMLS (NCI) C0011486) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 74. deamination
- [The removal of an amino group (NH2) from a chemical compound. ( MSH )] (UMLS (CSP) C0011061) =Natural Phenomenon or Process ;
|
- 25. 2'-Deoxythymidine
- [A pyrimidine nucleoside component of DNA comprised of thymidine linked by its N1 nitrogen to the C1 carbon of deoxyribose. ( NCI )] (UMLS (NCI) C0086126) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 75. Death
- (UMLS (HL7) C1546949) =Idea or Concept =Event Consequence;
|
- 26. 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
- [family of isoprenoid quinones which serve as mitochondrial electron transport cofactors. ( CSP )] (UMLS (NCI) C0041536) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =Benzoquinone Compound;
cofactor | - 76. Death
- [cessation of life; permanent cessation of all vital bodily functions.(CSP)] (UMLS (ICPC) C0011065) (Death; HERIOTZA (ESKL.PERINATALA); Dod (ex perinatal); Dood/overlijden (ex perinataal); KUOLEMA (EI PERINATAALINEN); Mort (SF perinatale); Tod (ex perinatal); mavet; exitus (kiv. perinatalis); Morte(escl perinatale); DOD/DODSFALL EKS A95; Morte (excl perinatal) ; Fallecimiento (ex perinatal); DOD (EXKL PERINATAL)) Dead =Organism Function ;
=life cycle; Pathologic Process; GENERAL AND UNSPECIFIED; Diagnosis/Diseases Component =autopsy; ASPHYXIA; brain death; cadaver; Death, Sudden; Drowning; Death, Intrauterine Fetal; Embryo Loss |
- 27. 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose
- [2-deoxy-2-(3-methyl-3-nitrosoureido) -D-glucopyranose; USP antineoplastic antibiotic; at high doses it destroys pancreatic beta cells and can be used to create experimental animal models of diabetes mellitus. ( CSP )] (UMLS (NCI) C0038432) =Carbohydrate; Antibiotic ;
=[AM300] AMINOGLYCOSIDES;
antineoplastic antibiotics;
nitrosourea;
=STREPTOZOCIN 1 GM/VIL;
| - 77. Death Adverse Event Not Associated with More Specific CTCAE Term NOS
- (UMLS (NCI) C1306577) Death NOS;
Death/Expired;
Expired/death;
Patient Death;
Patient Expired =Finding |
- 28. 2-Deoxyphenobarbital
- [An analog of phenobarbital with antiepileptic property. Although the mechanism of action has not been fully elucidated, primidone probably exerts its actions, in a manner similar to phenobarbital, via activation of gamma-aminobutyric acid (GABA)-A receptor/chloride ionophore complex, which leads to prolonged and increased frequency of opening of the chloride channel within the receptor complex. This results in an alteration in the electrical activity of the nerve cell membrane, causing hyperpolarization and prevention of partial and tonic-clonic seizures. In addition, this agent is partially metabolized to phenobarbital and phenylethylmalonamide (PEMA), which may also contribute to its anti-seizure properties. ( NCI )] (UMLS (NCI) C0033148) =Organic Chemical; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione =PRIMIDONE 250 MG;
PRIMIDONE 50 MG;
PRIMIDONE 250 MG/5ML | - 78. death certificate
- [form signed by the attending physician indicating an individual's time and cause of death. ( CSP )] (UMLS (CSP) C0011066) =Manufactured Object ;
=health related legal;
|
- 29. 3 DEG BRN W LOSS LEG-MLT
- [ ] (UMLS (ICD9CM) C0161314) =Injury or Poisoning
| - 79. Death occurring in less than 24 hours from onset of symptoms, not otherwise explained
- (UMLS (ICD9CM) C0277590) =Pathologic Function
|
- 30. 3 DEG BRN W LOSS-LEG NOS
- [ ] (UMLS (ICD9CM) C0161307) =Injury or Poisoning
| - 80. Death Rate
- (UMLS (NCI) C0205848) =Quantitative Concept ;
|
- 31. 3 DEG BRN W LOSS-LOW LEG
- [ ] (UMLS (ICD9CM) C0161311) =Injury or Poisoning
| - 81. death record
- [ ] (UMLS (CSP) C0011069) =Manufactured Object ;
|
- 32. 3 DEG BURN BACK OF HAND
- [ ] (UMLS (ICD9CM) C0161238) =Injury or Poisoning
| - 82. Death Valley Timbi-Sha Shoshone Band of California
- (UMLS (HL7) C1554291) =Population Group =NativeEntityContiguous;
|
- 33. 3 DEG BURN FINGR W THUMB
- [ ] (UMLS (ICD9CM) C0161236) =Injury or Poisoning
| - 83. Death, Intrauterine Fetal
- [Death in utero; failure of the product of conception to show evidence of respiration, heart beat, or definite movement of a voluntary muscle after expulsion from the uterus, with no possibility of resuscitation. ( NCI )] (UMLS (NCI) C0015927) =Pathologic Function ;
=Dead;
Pregnancy Complication =Fetal Resorption;
|
- 34. 3 DEG BURN W LOSS-ANKLE
- [ ] (UMLS (ICD9CM) C0161310) =Injury or Poisoning
| - 84. DEBILITY NOS
- [ ] (UMLS (ICD9CM) C0347947) =Pathologic Function
|
- 35. 3 DEG BURN W LOSS-FOOT
- [ ] (UMLS (ICD9CM) C0161309) =Injury or Poisoning
| - 85. Debrazza monkey
- [ ] (UMLS (CSP) C0598111) =Mammal
|
- 36. 3 DEG BURN W LOSS-KNEE
- [ ] (UMLS (ICD9CM) C0161312) =Injury or Poisoning
| - 86. DEBRID OPEN FX-HUMERUS
- [ ] (UMLS (ICD9CM) C0186489) =Therapeutic or Preventive Procedure
|
- 37. 3 DEG BURN W LOSS-THIGH
- [ ] (UMLS (ICD9CM) C0161313) =Injury or Poisoning
| - 87. DEBRID OPN FX-FEMUR
- [ ] (UMLS (ICD9CM) C0187862) =Therapeutic or Preventive Procedure
|
- 38. 3 DEG BURN W LOSS-TOE
- [ ] (UMLS (ICD9CM) C0375684) =Injury or Poisoning
| - 88. DEBRID OPN FX-FINGER
- [ ] (UMLS (ICD9CM) C0187303) =Therapeutic or Preventive Procedure
|
- 39. 3' deoxyadenosine
- [An anticancer drug that belongs to a family of drugs called antitumor antibiotics. ( NCI )] (UMLS (CSP) C0056331) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 89. DEBRID OPN FX-METAC/CAR
- [ ] (UMLS (ICD9CM) C0177470) =Therapeutic or Preventive Procedure
|
- 40. 3'-Deoxyadenosine-5'-(tetrahydrogen triphosphate)
- [The triphosphate salt of Cordycepin, a purine nucleoside antimetabolite analogue and antibiotic isolated from the fungus Cordyceps militaris with potential antineoplastic activity. Cordycepin incorporates into RNA, and, inhibits RNA chain elongation and synthesis due to the absence of a hydroxyl moiety at the 3' position. Because it is converted to an inactive metabolite by adenosine deaminase, this agent must be administered with an adenosine deaminase inhibitor in order to be effective. Cordycepin has displayed cytotoxicity against some leukemic cell lines in vitro. (NCI04) ( NCI )] (UMLS (NCI) C0046803) =Nucleic Acid, Nucleoside, or Nucleotide; Antibiotic
| - 90. DEBRID OPN FX-METAT/TAR
- [ ] (UMLS (ICD9CM) C0188570) =Therapeutic or Preventive Procedure
|
- 41. 3-Deazaguanine
- [A purine nucleoside analogue with antineoplastic and antiviral activity. By replacing guanine, dezaguanine incorporates into DNA and inhibits de novo purine synthesis, thereby inducing cell death. (NCI) ( NCI )] (UMLS (NCI) C0047332) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 91. DEBRID OPN FX-RADIUS/ULN
- [ ] (UMLS (ICD9CM) C0186555) =Therapeutic or Preventive Procedure
|
- 42. 4'-Demethylepipodophyllotoxin 9-[4,6-O-ethylidene-beta-D-glucopyranoside
- [glucopyranosyl substituted naphthalene derived from podophyllin; mutagen and immunosuppressant used in combination antineoplastic therapy for several human malignancies. ( CSP )] (UMLS (NCI) C0015133) =Carbohydrate; Pharmacologic Substance ;
=[AN000] ANTINEOPLASTICS;
Glucosides;
[IM600] IMMUNE SUPPRESSANTS;
Mutagen;
Mayapple Extract;
PODOFILOX =Etoposide Phosphate;
ETOPOSIDE 20 MG/ML;
ETOPOSIDE 50 MG;
ETOPOSIDE 100 MG;
ETOPOSIDE 200 MG;
ETOPOSIDE 500 MG;
| - 92. DEBRID OPN FX-TIBIA/FIB
- [ ] (UMLS (ICD9CM) C0187941) =Therapeutic or Preventive Procedure
|
- 43. 4'-Deoxy-20',20'-difluoro-C'-norvincaleukoblastine
- [A novel fluorinated Vinca alkaloid with antiangiogenic and antitumor activities. Although the exact mechanism of the mitotic block is not clear, vinflunine could induce cell cycle arrest at G2/M phase, and cause a concentration-dependent reduction of the microtubular network of interphase cells, thereby leading to apoptosis. This agent appears to function as an inhibitor of tubulin assembly, while exhibiting quantitatively different behaviors and showing lower binding capacity than the classic Vinca alkaloids. Furthermore, vinflunine exhibits improved pharmacokinetic properties, including increased lipophilicity, and is more resistant to metabolic degradation. ( NCI )] (UMLS (NCI) C0672663) =Organic Chemical; Pharmacologic Substance ;
| - 93. DEBRID OPN FX-TOE
- [ ] (UMLS (ICD9CM) C0188571) =Therapeutic or Preventive Procedure
|
- 44. 4'-Deoxy-4'-Iododoxorubicin
- [A substance that is being studied as a treatment for cancer, and for primary systemic amyloidosis (a disease in which proteins are deposited in specific organs). It belongs to the family of drugs called anthracycline analogues. ( NCI )] (UMLS (NCI) C0047758) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 94. debridement
- [The removal of foreign material and devitalized or contaminated tissue from or adjacent to a traumatic or infected lesion until surrounding healthy tissue is exposed. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0011079) =Therapeutic or Preventive Procedure ;
|
- 45. 4'-Deoxyadriamycin
- [A synthetic derivative of the anthracycline antineoplastic antibiotic doxorubicin. Esorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent exhibits less cardiotoxicity than the parent antibiotic doxorubicin, but may cause severe myelosuppression. (NCI04) ( NCI )] (UMLS (NCI) C0047760) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 95. DEBRIDEMENT OF NAIL
- [ ] (UMLS (ICD9CM) C0191729) =Therapeutic or Preventive Procedure
|
- 46. 4'-Deoxyadriamycin Hydrochloride
- (UMLS (NCI) C0955070) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 96. Debridement of open fracture of other specified bone, except facial bones
- [ ] (UMLS (ICD9CM) C0177472) =Therapeutic or Preventive Procedure
|
- 47. 4'-Deoxyepivincristine
- [A vinca alkaloid compound and semi-synthetic vincristine derivative with antineoplastic activity. Vinepidine binds to and stabilizes tubulin, thereby preventing tubulin polymerization and depolymerization, which result in microtubule assembly and disassembly, respectively. Treated cells are unable to complete mitosis process and are arrested in the metaphase, thereby leading to an inhibition of cell growth. ( NCI )] (UMLS (NCI) C0078255) =Organic Chemical; Pharmacologic Substance ;
| - 97. Debridement of open fracture site
- [ ] (UMLS (ICD9CM) C0177469) =Therapeutic or Preventive Procedure
|
- 48. 4-dedimethylamino sancycline
- [An anticancer drug that may stop tumor growth by preventing the growth of new blood vessels into a solid tumor. ( NCI )] (UMLS (NCI) C0763138) 4-Dimethlyamino Sancycline;
4-Dimethlyaminosancycline;
6-deoxy, 6-demethyl, 4-de-dimethylamino tetracycline;
6-deoxy-6-demethyl-4-dedimethylaminotetracycline;
CMT-3;
COL 3;
COL-3 =Organic Chemical; Pharmacologic Substance | - 98. Debridement of Ulcer
- (UMLS (NCI) C0730126) =Therapeutic or Preventive Procedure
|
- 49. 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine
- [An anticancer drug that belongs to the family of drugs called antimetabolites. ( NCI )] (UMLS (NCI) C0671970) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
deoxycytidine =CAPECITABINE 150 MG;
CAPECITABINE 500 MG | - 99. Debridement of Wound of Skin
- (UMLS (NCI) C0191342) =Therapeutic or Preventive Procedure
|
- 50. 5'-Deoxy-5-fluorouridine
- [A fluoropyrimidine derivative and oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) with antitumor activity. Doxifluridine, designed to circumvent the rapid degradation of 5-FU by dihydropyrimidine dehydrogenase in the gut wall, is converted into 5-FU in the presence of pyrimidine nucleoside phosphorylase. 5-FU interferes with DNA synthesis and subsequent cell division by reducing normal thymidine production and interferes with RNA transcription by competing with uridine triphosphate for incorporation into the RNA strand. ( NCI )] (UMLS (NCI) C0048808) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 100. debrisoquin
- [3,4-dihydro-2(H)-isoquinolinecarboxamidine (sulfate); oxidative metabolism of this drug is used to assay and model drug metabolism in general, especially genetic, ethnic, and individual pharmacokinetic differences. ( CSP )] (UMLS (CSP) C0011082) =Organic Chemical; Pharmacologic Substance =antihypertensive agent;
2 benzazine |
home
